The aim of Breathing Matters is to raise awareness and work with patients to help find a cure and develop better treatments for interstitial lung diseases, such as pulmonary fibrosis, and respiratory infections, such as bronchiectasis and pneumonia. The fund supports research carried out at UCL Respiratory to find better ways to diagnose and treat these diseases.
Research into the chronic lung disease, idiopathic pulmonary fibrosis which causes lung tissue to become thickened, stiff and scarred over a period of time.
Example: Investigating the role of platelets in IPF and other ILDs. We have studies looking at whether platelets accumulate in the lungs of patients with lung fibrosis, and whether platelets are abnormally ‘sticky’ in these patients.
Example: The Lung-COOL trial: Developing and defining the role of minimally invasive bronchoscopic cryoscopic lung biopsy in the diagnostic pathway of idiopathic interstitial lung disease.
Research into Bronchiectasis, which is a long-term condition where the airways of the lungs become abnormally widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infections.
Example: With the help of future funding the team will identify changes in bacterial and viral infection of the lung during exacerbations of bronchiectasis and recognise any genetic defects that might be the cause of idiopathic bronchiectasis.
By donating to Breathing Matters, you will help to progress the above research projects. Read more about the work.